Frequent Skin Cancers May Signal Risk of Other Cancers, Too

Frequent Skin Cancers May Signal Risk of Other Cancers, Too

THURSDAY, Aug. 9, 2018 (HealthDay News) — People who have frequent recurrences of a common skin cancer may be at increased risk of a range of other cancers, a new study suggests. Researchers found the heightened risk among patients who’d had many bouts of basal cell carcinoma (BCC) — a highly treatable form of skin cancer diagnosed in over 3 million Americans each year. Patients who’d developed at least six BCCs over 10 years showed higher-than-average risks of breast, colon, prostate and blood cancers. It’s well known that people who…

Read More

Spotlight On: Cancer Case Managers

Spotlight On: Cancer Case Managers

If you’ve been diagnosed with cancer, you will interact with a number of different members of the health care team at various times during treatment. When you walk into a doctor’s office, hospital, or cancer center, you may encounter nurses, physician assistants, social workers, doctors—the list goes on. In the Spotlight On series, we talk with some of these health care professionals to learn more about their jobs and the role they play in providing high-quality cancer care. A cancer diagnosis can be overwhelming. All the information about treatments and…

Read More

New Treatment for Non-Hodgkin Lymphoma Approved

New Treatment for Non-Hodgkin Lymphoma Approved

WEDNESDAY, Aug. 8, 2018 (HealthDay News) — Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma. The drug was approved to treat relapsed or refractory mycosis fungoides (MF) and Sézary syndrome (SS) after the patient has had at least one prior therapy delivered through the bloodstream. “Mycosis fungoides and Sézary syndrome are rare, hard-to-treat types of non-Hodgkin lymphoma and this approval fills an unmet medical need for these patients,” Dr. Richard Pazdur, director of the FDA’s Oncology…

Read More

Cancer, Depression, and Suicide Risk: Signs to Watch For

Cancer, Depression, and Suicide Risk: Signs to Watch For

Dr. William Breitbart is Chairman of the Jimmie C. Holland Chair in Psychiatric Oncology and is the Attending Psychiatrist, Psychiatry Service, in the Department of Psychiatry & Behavioral Sciences at Memorial Sloan Kettering Cancer Center (MSKCC). He’s also Attending Psychiatrist, Supportive Care Service, in the Department of Medicine at MSKCC and Professor of Clinical Psychiatry and Vice Chair, Department of Psychiatry, at Weill Cornell Medical College. Cancer can be an emotional experience, and sadness is a very common emotional response to a diagnosis or to the various events that can…

Read More

The Dark Side of Sunless Tanning

The Dark Side of Sunless Tanning

FRIDAY, Aug. 3, 2018 (HealthDay News) — Don’t kid yourself that using a sunless tanning product will prevent skin cancer. Unless you’re willing to stop sunbathing altogether, you’re still at risk for skin damage, researchers report. “For the most part, adults who use sunless tanning products continue to engage in risky tanning behaviors,” said study leader Matthew Mansh, a dermatology resident at the University of Minnesota Medical School. Sunless tanners include sprays, ointments, creams, foams or lotions. They’re touted as a safe alternative to outdoor sunbathing or indoor tanning. But…

Read More